Self-consent for the HPV vaccine

Not Applicable

Completed

• Conditions: Self-consent for HPV vaccination programme; Infections and Infestations

• Registration Number: ISRCTN49086105
• Lead Sponsor: niversity of Bristol

Brief Summary

2018 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/29502095 2020 results in https://doi.org/10.1093/pubmed/fdaa164 (added 16/02/2021) 2020 qualitative results in https://pubmed.ncbi.nlm.nih.gov/33172415/ (added 16/02/2021) 2020 qualitative results (2) in https://pubmed.ncbi.nlm.nih.gov/33041101/ (added 16/02/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-01-12
• Study Completion: 2020-01-31
• Last Update Posted: 1 March 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

1. Young women who were involved in the new self-consent procedures for the HPV vaccination programme at a participating school
2. Parents/carers of young women who were involved in the new self-consent procedures for the HPV vaccination programme at a participating school
3. Healthcare professionals involved in the delivery of the HPV vaccination programme at participating schools
4. Key school staff involved in the delivery of the HPV vaccination programme at participating schools

Exclusion Criteria

1. Participants who do not have capacity to provide informed consent/assent
2. Participants who are unable to communicate in English

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
% change of HPV vaccination programme uptake before and after implementation of self-consent procedures

Secondary Outcome Measures

Name	Time	Method
<br> 1. % change in HPV vaccination programme uptake in intervention site in comparison to comparison sites<br> 2. Barriers and facilitators to implementation of self-consent procedures from perspectives of young women, parents, immunisation nurses and school staff<br>